Hao Huang

2.0k total citations
80 papers, 1.2k citations indexed

About

Hao Huang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hao Huang has authored 80 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 25 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hao Huang's work include RNA modifications and cancer (19 papers), Cancer-related molecular mechanisms research (14 papers) and RNA Research and Splicing (13 papers). Hao Huang is often cited by papers focused on RNA modifications and cancer (19 papers), Cancer-related molecular mechanisms research (14 papers) and RNA Research and Splicing (13 papers). Hao Huang collaborates with scholars based in China, Hong Kong and United States. Hao Huang's co-authors include Xin Wang, Yong Han, Xin Deng, Like Qu, Chengchao Shou, Ajay Goel, Tingting Wang, Xiaolong Shao, Yingchao Zhang and Yingpeng Xie and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hao Huang

75 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Huang China 21 797 354 245 176 116 80 1.2k
Aurélie Bedel France 20 888 1.1× 255 0.7× 248 1.0× 123 0.7× 155 1.3× 41 1.3k
Toshiyuki Tsunoda Japan 23 843 1.1× 333 0.9× 328 1.3× 160 0.9× 88 0.8× 77 1.3k
Jian Chai China 7 687 0.9× 283 0.8× 315 1.3× 115 0.7× 84 0.7× 16 1.1k
Weiwei Li China 21 959 1.2× 380 1.1× 218 0.9× 135 0.8× 200 1.7× 72 1.5k
Lin Cao China 19 732 0.9× 342 1.0× 212 0.9× 83 0.5× 58 0.5× 49 1.1k
Marten Hornsveld Netherlands 13 811 1.0× 325 0.9× 366 1.5× 90 0.5× 107 0.9× 20 1.2k
D. Alwyn Dart United Kingdom 18 1.1k 1.3× 594 1.7× 258 1.1× 179 1.0× 117 1.0× 39 1.4k
Davide Corà Italy 23 1.2k 1.5× 619 1.7× 195 0.8× 150 0.9× 129 1.1× 58 1.7k
Hailing Yang United States 23 944 1.2× 270 0.8× 364 1.5× 130 0.7× 67 0.6× 58 1.5k
Zihuan Yang China 21 678 0.9× 321 0.9× 272 1.1× 130 0.7× 44 0.4× 57 1.1k

Countries citing papers authored by Hao Huang

Since Specialization
Citations

This map shows the geographic impact of Hao Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Huang more than expected).

Fields of papers citing papers by Hao Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Huang. The network helps show where Hao Huang may publish in the future.

Co-authorship network of co-authors of Hao Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Huang. A scholar is included among the top collaborators of Hao Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Huang. Hao Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Yu, Hao Huang, Wenyong Zhu, et al.. (2025). The dual role of CXCL9/SPP1 polarized tumor-associated macrophages in modulating anti-tumor immunity in hepatocellular carcinoma. Frontiers in Immunology. 16. 1528103–1528103. 1 indexed citations
2.
Lan, Jing, Wei Dai, Hao Huang, et al.. (2025). A Review of Bavachinin and Its Derivatives as Multi‐Therapeutic Agents. Chemistry & Biodiversity. 22(6). e202402762–e202402762.
3.
Guo, Tao, Yurong Zou, Minghai Tang, et al.. (2025). Discovery and Pharmacological Evaluation of Potent and Highly Selective PARP1 Inhibitors. Journal of Medicinal Chemistry. 68(13). 13491–13515. 3 indexed citations
6.
Zhu, Wenxing, Hao Huang, Qiong Li, et al.. (2025). Dissecting the Emerging Regulatory and Mechanistic Paradigms of Transcribed Conserved Non-Coding Elements in Breast Cancer. Biomolecules. 15(5). 627–627.
7.
Lai, Huasheng, et al.. (2024). Advances in Surface-Enhanced Raman Spectroscopy for Therapeutic Drug Monitoring. Molecules. 30(1). 15–15. 4 indexed citations
10.
Hu, Jianyang, Hao Huang, Tan Wu, et al.. (2024). FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer. Epigenetics & Chromatin. 17(1). 34–34. 1 indexed citations
11.
Huang, Hao, et al.. (2023). Downregulated FTO Promotes MicroRNA-155-mediated Inflammatory Response in Cerebral Ischemia/Reperfusion Injury. Neuroscience. 526. 305–313. 8 indexed citations
12.
Huang, Hao, Qi Tong, Meng Cao, et al.. (2023). Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma. Cancers. 15(8). 2338–2338. 12 indexed citations
14.
Zhu, Wenyong, Hao Huang, Rongxin Zhang, et al.. (2023). Delineating highly transcribed noncoding elements landscape in breast cancer. Computational and Structural Biotechnology Journal. 21. 4432–4445. 2 indexed citations
15.
Huang, Hao, et al.. (2022). The value of CT-based radiomics nomogram in differential diagnosis of different histological types of gastric cancer. Physical and Engineering Sciences in Medicine. 45(4). 1063–1071. 7 indexed citations
16.
Kuang, Xielan, Han Zhang, Han Tang, et al.. (2021). Lidocaine Inhibits Myoblast Cell Migration and Myogenic Differentiation Through Activation of the Notch Pathway. Drug Design Development and Therapy. Volume 15. 927–936. 4 indexed citations
17.
Huang, Hao, Jianyang Hu, Qinghua Huang, et al.. (2021). Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling. Nature Communications. 12(1). 2242–2242. 76 indexed citations
18.
Huang, Hao, et al.. (2020). SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma. Disease Markers. 2020. 1–9. 26 indexed citations
19.
Liu, Bo, Jingping Liu, Kun Liu, et al.. (2019). A prognostic signature of five pseudogenes for predicting lower-grade gliomas. Biomedicine & Pharmacotherapy. 117. 109116–109116. 35 indexed citations
20.
Tao, Yifeng, et al.. (2017). Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features. BioMed Research International. 2017. 1–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026